1. Home
  2. VTVT vs ACCS Comparison

VTVT vs ACCS Comparison

Compare VTVT & ACCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VTVT
  • ACCS
  • Stock Information
  • Founded
  • VTVT 2015
  • ACCS 1988
  • Country
  • VTVT United States
  • ACCS United States
  • Employees
  • VTVT N/A
  • ACCS N/A
  • Industry
  • VTVT Biotechnology: Pharmaceutical Preparations
  • ACCS Publishing
  • Sector
  • VTVT Health Care
  • ACCS Consumer Discretionary
  • Exchange
  • VTVT Nasdaq
  • ACCS Nasdaq
  • Market Cap
  • VTVT 47.9M
  • ACCS 42.6M
  • IPO Year
  • VTVT 2015
  • ACCS N/A
  • Fundamental
  • Price
  • VTVT $22.12
  • ACCS N/A
  • Analyst Decision
  • VTVT Strong Buy
  • ACCS Strong Buy
  • Analyst Count
  • VTVT 2
  • ACCS 1
  • Target Price
  • VTVT $35.50
  • ACCS $14.00
  • AVG Volume (30 Days)
  • VTVT 5.9K
  • ACCS 5.6K
  • Earning Date
  • VTVT 11-11-2025
  • ACCS 11-06-2025
  • Dividend Yield
  • VTVT N/A
  • ACCS N/A
  • EPS Growth
  • VTVT N/A
  • ACCS N/A
  • EPS
  • VTVT N/A
  • ACCS N/A
  • Revenue
  • VTVT $17,000.00
  • ACCS $22,562,000.00
  • Revenue This Year
  • VTVT N/A
  • ACCS $0.03
  • Revenue Next Year
  • VTVT N/A
  • ACCS $11.45
  • P/E Ratio
  • VTVT N/A
  • ACCS N/A
  • Revenue Growth
  • VTVT N/A
  • ACCS 26.44
  • 52 Week Low
  • VTVT $12.62
  • ACCS $7.79
  • 52 Week High
  • VTVT $26.99
  • ACCS $13.35
  • Technical
  • Relative Strength Index (RSI)
  • VTVT N/A
  • ACCS N/A
  • Support Level
  • VTVT N/A
  • ACCS N/A
  • Resistance Level
  • VTVT N/A
  • ACCS N/A
  • Average True Range (ATR)
  • VTVT 0.00
  • ACCS 0.00
  • MACD
  • VTVT 0.00
  • ACCS 0.00
  • Stochastic Oscillator
  • VTVT 0.00
  • ACCS 0.00

About VTVT vTv Therapeutics Inc.

vTv Therapeutics Inc is a clinical stage biopharmaceutical company focused on the development of orally administered treatments for metabolic and inflammatory diseases to minimize their long-term complications and improve the lives of patients. Its product pipeline include TTP399, TTP273, HPP737, HPP593, Azeliragon, HPP971, HPP3033, and TTP-RA.

About ACCS ACCESS Newswire Inc.

ACCESS Newswire Inc is a Public Relations (PR) and Investor Relations (IR) solutions provider. The group focuses on innovation, customer service, and value-driven offerings, ACCESS Newswire empowers brands.

Share on Social Networks: